Fact CheckerSign in

NCT07478042Completed

Guiding Catheters in Endovascular Stroke Therapy - Are Balloon Guided Catheters Superior?

Sind Ballonassistierte Führungskatheter in Der Endovaskulären Schlaganfalltherapie Der Vorderen Zirkulation überlegen? (BEST-Studie) Guiding Catheters in Endovascular Stroke Therapy - Are Balloon Guided Catheters Superior?

Source: ClinicalTrials.gov · Last updated 17 Mar 2026

Brief summary (registry, in English)

The BEST study is an academically initiated, single-center, prospective, randomized controlled clinical trial investigating the potential advantages and disadvantages of using a guide catheter with or without a balloon in the interventional treatment of acute ischemic stroke. The study population consists of adult patients with acute ischemic stroke of the anterior circulation for whom interventional recanalization therapy via catheter is indicated following interdisciplinary consultation between the Department of Neurology and Neuroradiology at Heidelberg University Hospital. In addition to routine clinical treatment measures and data collection, patients will be interviewed by telephone after 90 days to assess their quality of life and level of independence using standardized scoring systems. All medical devices used or investigated in this study bear the CE mark (Conformité Européenne ) and will be used within their intended purpose. Study participants will not be subjected to any additional invasive or burdensome procedures beyond normal usage.

Status (registry)
Completed
Study type
Interventional
Enrollment
110 (actual)
First submitted
10 Feb 2026
Start date
15 Mar 2023
Primary completion date
30 Jul 2025
Lead sponsor
University Hospital Heidelberg
Diseases
Stroke
NCT number
NCT07478042

What you commit to

  • Study type: Interventional
  • Participants enrolled: 110
  • From 15 Mar 2023 to the primary completion date, 30 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with contraindications to interventional therapy

Other illness

  • Patients with acute intracranial hemorrhage
  • National Institute of Health Stroke Scale (NIHSS) ≤ 4

Other

  • Pregnancy/Breastfeeding
  • Pre-therapeutic mRS \> 3
  • Patients detained in an institution by court or government order
  • Patients who require intubation for treatment

Who the study is looking for

  • Patients with an acute ischemic stroke
  • Location of the primary occlusion in the anterior cerebral circulation
  • Pre-therapeutic modified Rankin Scale (mRS) score of ≤ 3.
  • Written informed consent from
    • the patient or
    • their legal representative/guardian or
    • patient enrollment by an independent physician and the principal investigator

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Heidelberg
Coordinator of this site? Confirm its status
HeidelbergGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.